MarketBeat reported consensus ratings, Geode Capital Management raised its stake, Citigroup reissued a buy rating, and Benchmark restated a speculative buy rating regarding Intensity Therapeutics.
1 report, 1 independent
Updated Aug 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat reported consensus ratings, Geode Capital Management raised its stake, Citigroup reissued a buy rating, and Benchmark restated a speculative buy rating regarding Intensity Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Citigroup
American investment bank and financial services corporation
-
Benchmark
venture capital firm
- The Bank of England, FED, and market experts are discussing how the ongoing Iran conflict and geopolitical tensions are driving up energy costs and influencing global financial rates.
- MarketBeat published a buy rating and target price increase for a company, with disclosures made under a Rule 10b5-1 trading plan.
Related events
- MarketBeat reports consensus rating, Citigroup restates a market outperform rating, and Jefferies Financial Group sets a $28.00 target price for Four Corners Property Trust.
- MarketBeat reported a Moderate Buy consensus rating for Genelux, while Benchmark reissued a speculative buy rating, and an insider sold shares.
- MarketBeat reported the stock consensus rating for Phunware on September 8, 2026.
- MarketBeat reported recent stock ratings for Innovative Solutions and Support, Inc. and TechPrecision Corporation.
- Geode Capital Management increased its holdings in Omnicom Group, while Citigroup lowered its price target and rating.